Baiqiang Dong

Dr. Baiqiang Dong

orcid

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
14 June 2019 in BMC Cancer
Verified
Journal Article
Open access
PDF file
GCGuofu Chen
Guofu Chen
BDBaiqiang Dong
Baiqiang Dong
GSGuoping Shan
Guoping Shan
XZXiuqin Zhang
Xiuqin Zhang
HTHuarong Tang
Huarong Tang
WJWang Jin
Wang Jin
An accurate, reproducible, and comfortable immobilization device is essential for stereotactic radiotherapy (SBRT) in patients with lung cancer. This study compared thermoplastic masks (TMP) and vacuum cushion (VCS) system to assess the differences in interfraction and intrafraction setup accuracy and the impact of body mass index (BMI) with respect to the immobilization choice. This retrospective study was conducted on patients treated with lung SBRT between 2012 and 2015 at the Zhejiang cancer hospital. The treatment setup accuracy was analyzed in 121 patients. A total of 687 cone beam computed tomography (CBCT) scans before treatment and 126 scans after treatment were recorded to determine the uncertainties, and plan target volume margins. Data were further stratified and analyzed by immobilization methods and patients’ BMI. The t-test (Welch) was used to assess the differences between the two immobilization systems when stratified by the patients’ BMI. For patients with BMI ≥ 24, the mean displacements for the TMP and VCS systems were 1.4 ± 1.2 vs. 2.4 ± 2.0 mm at medial-lateral (ML) direction (p < 0.001); 2.0 ± 1.9 vs. 2.0 ± 1.9 mm at cranial-caudal (CC) direction (p = 0.917); and 2.4 ± 1.4 vs. 2.6 ± 2.1 mm at anterior-posterior (AP) direction, (p = 0.546). The rate of acceptable errors increased dramatically when immobilized by TMP. In the case of patients with BMI < 24, the mean displacements for the TMP and VCS systems were 1.8 ± 1.4 vs. 2.1 ± 1.8 mm at ML direction (p = 0.098); 2.9 ± 2.3 vs. 2.2 ± 2.2 mm at CC direction (p = 0.001); and 1.8 ± 1.8 vs. 2.3 ± 2.0 mm at CC direction, (p = 0.006). The proportion of acceptable errors increased after immobilization by VCS. No difference was detected in the intrafraction setup error by different immobilization methods. The immobilization choice of SBRT for lung tumors depends on the BMI of the patients. For patients with BMI ≥ 24, TMP offers a better reproducibility with significantly less interfractional setup displacement than VCS, resulting in fewer CBCT scans. However, VCS may be preferred over TMP for the patients with BMI < 24. Therefore, an optimal immobilization system needs to be considered in different BMI groups for lung SBRT.

18 November 2022 in Medicine
Verified
Journal Article
Open access
JJJia-Nan Mm Jin
Jia-Nan Mm Jin
YPYUE PENG
YUE PENG
YHYue Hao
Yue Hao
SWShi-Yan Mm Wu
Shi-Yan Mm Wu
BDBaiqiang Dong
Baiqiang Dong
MCMing Chen
Ming Chen
Oligometastatic non-small-cell lung cancer (NSCLC) is potentially curable. Oligo-recurrence occurs with oligometastatic disease characterized by well-controlled primary lesion. The purpose of the present study was to explore the value of definitive local therapy (DLT) for extracranial single-organ oligorecurrent NSCLC. A total of 81 patients with NSCLC who had extracranial single-organ oligorecurrence after receiving radical treatment at the Cancer Hospital of the University of Chinese Academy of Sciences from January 2010 to December 2017 were analyzed. The primary endpoint was progression-free survival (PFS), and the secondary endpoint was overall survival (OS). The median follow-up time of the 81 patients was 65.8 months. A total of 39 patients received DLT. A large proportion of patients who did not accept DLTs received specific tyrosine kinase inhibitors (TKIs). The results of multivariate analysis showed that DLT and specific TKI therapy were favorable prognostic factors significantly related to PFS. Further analysis showed that for patients without specific TKI therapy, DLT significantly improved PFS and the 5-year PFS rate. The 5-year OS rate also improved, but the improvement was not significant. For extracranial single-organ oligorecurrent NSCLC, PFS was significantly superior in patients receiving DLT. Among them, for the subgroup of patients who did not receive specific TKI therapy, DLT is expected to improve long-term prognostic outcomes.

16 December 2022 in Research Square
Verified
Preprint
Open access
PDF file
BDBaiqiang Dong
Baiqiang Dong
XZXuan Zhu
Xuan Zhu
KLKai Li
Kai Li
MCMing Chen
Ming Chen
Background: Glycolysis affects tumor growth, invasion, treatment resistance, and the tumor microenvironment. In this study, we aimed to construct a glycolysis-related prognostic signature for lung adenocarcinoma (LUAD) and analyze its relationship with the tumor microenvironment (TME). Methods: We analyzed the data of a training set from The Cancer Genome Atlas (TCGA) database and four validation cohorts from the Gene Expression Omnibus (GEO) databases which included 1,689 patients with LUAD. The genetic and transcriptional alterations of glycolysis-related genes (GRGs) were investigated, and evaluated their prognostic value in LUAD patients. The glycolysis-related patterns were identified using consensus unsupervised clustering analysis. A glycolysis-related prognostic signature was then established using the least absolute shrinkage and selection operator and Cox regression analysis. Gene set variation, clinical relevance, and TME analyses were conducted to explain the biological functions of glycolysis regulators and their performance in prognostic prediction. Results: The glycolysis-related patterns were identified based on 18 GRGs, with significant differences in survival between the patterns. By screening of differentially expressed genes between patterns, a novel glycolysis-related prognostic signature was final obtained, including ALDOA, FOSL2, PDE6D, PPARD, and RASAL2, with robust and accurate prognostic performance. The high-, and low risk groups, distinguished by the signature formula, presented a significant difference in overall survival, TME, and immunotherapy response in LUAD patients. The potential roles of the glycolysis-related prognostic signature were confirmed using the validation dataset. Conclusions: This study identified five glycolysis-related prognostic genes that effectively predicted the survival of LUAD. To a certain extent, the newly identified gene signature was related to the TME, especially immune cell infiltration. These findings provide potential biomarkers and therapeutic targets for LUAD.